ADIPOQ and coronary artery disorder: As previously shown in a study of German patients on chronic hemodialysis [18], the current study in a Chinese cohort of CAD and non-CAD patients also demonstrated an independent relationship between FGF19 and adiponectin which was suggested to be beneficial to metabolic profile.